Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

12.5%

1 terminated/withdrawn out of 8 trials

Success Rate

87.5%

+1.0% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

43%

3 of 7 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

Early Phase 1
2(33.3%)
N/A
2(33.3%)
Phase 1
2(33.3%)
6Total
Early Phase 1(2)
N/A(2)
Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT05115513Phase 1Completed

Standardized Field Test for Marijuana Impairment II

Role: collaborator

NCT04856566Early Phase 1Completed

Examine the Feasibility of a Standardized Field Test for Marijuana and Alcohol Impairment: Laboratory Evaluations

Role: collaborator

NCT03191084Early Phase 1Completed

Examine the Feasibility of a Standardized Field Test for Marijuana Impairment: Laboratory Evaluations

Role: collaborator

NCT04970342Phase 1Completed

Validation of the Drug Impaired Driving Scenario (DIDS) on the CRCDS-miniSim

Role: collaborator

NCT04218279Not ApplicableTerminated

The EMS Sleep Health Study: A Randomized Controlled Trial

Role: collaborator

NCT01620177Not ApplicableCompleted

Effects of Inhaled Cannabis on Driving Performance

Role: collaborator

NCT02713503Completed

Evaluating Electronic Devices in a Driving Simulator

Role: collaborator

NCT01265316Completed

Measurement of the Quality of Pediatric CPR

Role: collaborator

All 8 trials loaded